Effective date

Selectis Health Enters Definitive Purchase and Sale Agreement for Archway Transitional Care Center in Georgia

Retrieved on:

Giovedì, Maggio 9, 2024

Sale, OTC, PSA, Effective date, Inspection, GBCS, Good Will Hunting, Village, Commercial property

Greenwood Village, Colorado, May 09, 2024 (GLOBE NEWSWIRE) -- Selectis Health, Inc. (OTC: GBCS) ("Selectis" or the "Company") announced that its wholly-owned subsidiary, Goodwill Hunting, LLC (the “Seller”), has executed and delivered a definitive Purchase and Sale Agreement (the “PSA”) to sell certain real property located in Macon, Bibb County, Georgia, including the skilled nursing facility known as Archway Transitional Care Center1 (collectively, “the Archway Property”). Pursuant to the PSA, Bibb County Holdings II, LLC (the “Purchaser”) has agreed to purchase the Archway Property for $6.75 million, subject to certain prorations, holdbacks, and adjustments customary in transactions of this nature.

Key Points:

Greenwood Village, Colorado, May 09, 2024 (GLOBE NEWSWIRE) -- Selectis Health, Inc. (OTC: GBCS) ("Selectis" or the "Company") announced that its wholly-owned subsidiary, Goodwill Hunting, LLC (the “Seller”), has executed and delivered a definitive Purchase and Sale Agreement (the “PSA”) to sell certain real property located in Macon, Bibb County, Georgia, including the skilled nursing facility known as Archway Transitional Care Center1 (collectively, “the Archway Property”).
Pursuant to the PSA, Bibb County Holdings II, LLC (the “Purchaser”) has agreed to purchase the Archway Property for $6.75 million, subject to certain prorations, holdbacks, and adjustments customary in transactions of this nature.
The Seller and Purchaser entered into the PSA on May 1, 2024 (the “Effective Date”).
In the event of termination, the Purchaser shall receive a full refund of the initial $50,000 deposit delivered to the Seller’s escrow agent.

Bernstein Litowitz Berger & Grossmann LLP and Pomerantz LLP Announce Notice of Pendency and Proposed Settlement of Stockholder Class Action Involving Record and Beneficial Holders of DiamondPeak Holdings Corp. Class A Common Stock as of the Effective Time

Retrieved on:

Lunedì, Maggio 6, 2024

STOCKHOLDERS LITIGATION

Key Points:

STOCKHOLDERS LITIGATION
SUMMARY NOTICE OF PENDENCY AND PROPOSED SETTLEMENT OF STOCKHOLDER CLASS ACTION, SETTLEMENT HEARING, AND
TO: All record and beneficial holders of DiamondPeak Holdings Corp. ("DiamondPeak") Class A common stock as of the effective time (the "Effective Time") of the merger with Lordstown EV Corporation (f/k/a Lordstown Motors Corp.) on October 23, 2020 (the "Settlement Class").
Certain persons and entities are excluded from the Settlement Class by definition, as set forth in the full Notice of Pendency and Proposed Settlement of Stockholder Class Action, Settlement Hearing, and Right to Appear (the "Notice"), available at www.LordstownMotorsStockholdersLitigation.com .
your rights will be affected by a class action lawsuit pending in this court.
All questions about this Summary Notice, the proposed Settlement, or your eligibility to participate in the Settlement should be directed to the Settlement Administrator or Plaintiffs' Co-Lead Counsel.

Mission Bancorp Announces Extension of Stock Repurchase Plan and Declares 5.00% Annual Stock Dividend

Retrieved on:

Lunedì, Aprile 29, 2024

OTC Markets Group, Date, AJ, Effective date, Plan

BAKERSFIELD, Calif., April 29, 2024 /PRNewswire/ -- Mission Bancorp (OTC Pink: MSBC), announced today that its Board of Directors has extended its stock repurchase plan and approved a 5.00% stock dividend.

Key Points:

BAKERSFIELD, Calif., April 29, 2024 /PRNewswire/ -- Mission Bancorp (OTC Pink: MSBC), announced today that its Board of Directors has extended its stock repurchase plan and approved a 5.00% stock dividend.
The Company announced on October 27, 2023, the extension of its plan under Rule 10b5-1 (the "2022 10b5-1 Plan") to facilitate the repurchase of its common stock.
Pursuant to the 2022 10b5-1 Plan, a maximum of $1.0 million of the Company's common stock may be repurchased by the Company.
The extension authorizes the Company to repurchase its common stock up to a maximum of $1.0 million.

Zhihu Inc. Announces Plan to Implement ADS Ratio Change

Retrieved on:

Venerdì, Aprile 26, 2024

Chase Bank, Sale, Zhihu, JPMorgan Chase, ADS, Tax, Effective date, Security (finance)

For the Company's ADS holders, the ADS Ratio Change will have the same effect as a one-for-six reverse ADS split.

Key Points:

For the Company's ADS holders, the ADS Ratio Change will have the same effect as a one-for-six reverse ADS split.
No fractional new ADSs will be issued in connection with the ADS Ratio Change.
The ADS Ratio Change will have no impact on the Company's underlying Class A ordinary shares, and no ordinary shares will be issued or cancelled in connection with the ADS Ratio Change.
As a result of the ADS Ratio Change, the ADS trading price is expected to increase proportionately upon the effectiveness of the ADS Ratio Change, although the Company can give no assurance that the ADS trading price after the ADS Ratio Change will be equal to or greater than six times the ADS trading price before the change.

Biophytis announces ratio change under its American Depositary Receipt (“ADR”) program

Retrieved on:

Venerdì, Maggio 3, 2024

Euronext Growth, Ratio, ADS, Therapy, American depositary receipt, ADR, Effective date, Notifiable disease

The effective date of the Ratio Change (the “Effective Date”) is expected to be April 23, 2024.

Key Points:

The effective date of the Ratio Change (the “Effective Date”) is expected to be April 23, 2024.
ADS beneficial holders who hold through an ADR holder intermediary need not take any action in connection with the Ratio Change.
No new Shares will be issued in connection with the Ratio Change and this Ratio Change does not change the total number of Biophytis ordinary shares.
As a result of the Ratio Change, the trading price of the Company’s ADSs is expected to automatically increase proportionally, but the Company can give no assurance that the ADS trading price following the Ratio Change will be at least equal to the ADS trading price before the Ratio Change multiplied by the new 40:1 ratio.

Burning Rock Announces ADS Ratio Change

Retrieved on:

Venerdì, Aprile 26, 2024

Sale, London Stock Exchange, Depository Trust Company, NGS, ADS, Effective date, Security (finance)

GUANGZHOU, China, April 26, 2024 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing (NGS) technology in the field of precision oncology, today announced that it will change the ratio of its American depositary shares (the “ADSs”) to Class A ordinary shares from one (1) ADS representing one (1) Class A ordinary share to one (1) ADS representing ten (10) Class A ordinary shares (the “ADS Ratio Change”).

Key Points:

GUANGZHOU, China, April 26, 2024 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing (NGS) technology in the field of precision oncology, today announced that it will change the ratio of its American depositary shares (the “ADSs”) to Class A ordinary shares from one (1) ADS representing one (1) Class A ordinary share to one (1) ADS representing ten (10) Class A ordinary shares (the “ADS Ratio Change”).
For Burning Rock’s ADS holders, the ADS Ratio Change will have the same effect as a one-for-ten reverse ADS split.
No fractional new ADSs will be issued in connection with the change in the ADS Ratio Change.
As a result of the ADS Ratio Change, the ADS price is expected to increase proportionally, although the Company can give no assurance that the ADS price after the ADS Ratio Change will be equal to or greater than ten times the ADS price before the change.

Gabelli Equity Income Fund Reaffirms $1.20 Distribution Policy and Announces Conversion of C1 Class

Retrieved on:

Lunedì, Aprile 22, 2024

Prospectus, OTCQX, Policy, C1, GAMCO Investors, Effective date, Fund

GREENWICH, Conn., April 22, 2024 (GLOBE NEWSWIRE) -- The Board of Directors (the “Board”) of The Gabelli Equity Income Fund (the “Fund”) reaffirmed the Fund’s annual distribution rate of $1.20 per share.

Key Points:

GREENWICH, Conn., April 22, 2024 (GLOBE NEWSWIRE) -- The Board of Directors (the “Board”) of The Gabelli Equity Income Fund (the “Fund”) reaffirmed the Fund’s annual distribution rate of $1.20 per share.
If Class C1 shares are not redeemed prior to the Effective Date, each shareholder owning Class C1 shares of the Fund will own Class C shares of the Fund equal to the aggregate value of the shareholder’s Class C1 shares.
The Gabelli Equity Income Fund is managed by Gabelli Funds, LLC and distributed by G.distributors, LLC, subsidiaries of GAMCO Investors, Inc. (OTCQX: GAMI).
The distribution rate should not be considered the dividend yield or total return on an investment in the Fund.

NuCana Announces Completion of ADS Ratio Change

Retrieved on:

Martedì, Aprile 16, 2024

Sale, DTC, NCNA, Ratio, Depository Trust Company, ADS, Tax, Citibank, American depositary receipt, Effective date, FICC, DRS, Security (finance)

The ADS Ratio Change became effective on April 16, 2024 (the “Effective Date”).

Key Points:

The ADS Ratio Change became effective on April 16, 2024 (the “Effective Date”).
For the Company's ADS holders, the change in the ADS Ratio has the same effect as a one-for-twenty-five reverse ADS split and will have no impact on an ADS holder’s proportional equity interest in the Company.
The ADS Ratio Change affects all shareholders uniformly and will not alter any shareholder’s percentage interest in the Company’s equity, except to the extent that the ratio change would have resulted in a shareholder owning fractional ADSs.
As a result of the ADS Ratio Change, the ADS trading price is expected to increase proportionally, although the Company can give no assurance that the ADS trading price after the ADS Ratio Change will be proportionally equal to or greater than the previous ADS trading price prior to the change or that the Ratio Change will have any effect on the liquidity in the Company’s ADSs.

SABA’s Board of Trustees Approves Share Repurchase Program, Reverse Stock Split, and Declassification of Board of Trustees

Retrieved on:

Mercoledì, Maggio 1, 2024

The repurchase program will require reauthorization by the Board for each new fiscal year.

Key Points:

The repurchase program will require reauthorization by the Board for each new fiscal year.
The Board has approved a reverse stock split (the “Reverse Split”) of the Fund’s common shares at a ratio of 1-for-2.
As of the Effective Date, every two shares of the Fund’s issued and outstanding common shares will be converted into one common share.
The annual election of all trustees at once will align the Fund’s corporate governance to the best-in-class standard of the industry.

Rigrodsky Law, P.A. and Rowley Law PLLC Announce a Class Action and Proposed Settlement for All Persons Who Held Fewer Than 1,000 Shares of Westell Technologies, Inc. Common Stock

Retrieved on:

Lunedì, Aprile 15, 2024

YOUR RIGHTS WILL BE AFFECTED BY A CLASS ACTION LAWSUIT PENDING IN THIS COURT.

Key Points:

YOUR RIGHTS WILL BE AFFECTED BY A CLASS ACTION LAWSUIT PENDING IN THIS COURT.
If approved by the Court, the Settlement will resolve all claims in the Action against Defendants.
Class Members do not have to submit a claim form to receive a payment from the Settlement.
All questions about this notice, the proposed Settlement, or your eligibility to participate in the Settlement should be directed to the Settlement Administrator or Plaintiff's Counsel.